Fetuin-A and its genetic association with cardiometabolic disease
Abstract Fetuin-A acts as both an inhibitor of calcification and insulin signaling. Previous studies reported conflicting results on the association between fetuin-A and cardiometabolic diseases. We aim to provide further insights into the association between genetically predicted levels of fetuin-A...
Main Authors: | Lawien Al Ali, Yordi J. van de Vegte, M. Abdullah Said, Hilde E. Groot, Tom Hendriks, Ming Wai Yeung, Erik Lipsic, Pim van der Harst |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-48600-9 |
Similar Items
-
Heart Rate Recovery 10 Seconds After Cessation of Exercise Predicts Death
by: Yordi J. van de Vegte, et al.
Published: (2018-04-01) -
Search for a Functional Genetic Variant Mimicking the Effect of SGLT2 Inhibitor Treatment
by: Siqi Wang, et al.
Published: (2021-07-01) -
Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction
by: Lawien Al Ali, et al.
Published: (2023-01-01) -
Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
by: Mohammad A. Almesned, et al.
Published: (2021-12-01) -
Fetuin A and fetuin B as an indicator of liver fibrosis in hepatitis B
by: Şenol Arzu, et al.
Published: (2023-10-01)